Actual Medicinal Product (AMP) Prothiaden 25mg capsules (Stephar (U.K.) Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No stability data in MCAs available but no theoretical concerns with product.
Anecdotal reports of use in MCAs for up to 7 days (low quality evidence). - Provenance
-
This recommendation is based on the products Prothiaden 25mg capsules (Teofarma S.r.l) and dosulepin 25mg capsules (Sovereign Medical).
- Generic
- Dosulepin
- Formulation
- Dosulepin 25mg capsules
-
Dosulepin
-
Dosulepin 25mg capsules
-
Prothiaden 25mg capsules (Stephar (U.K.) Ltd)
-
-